Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 05/31 07:50:53 pm
112.45 USD   -0.54%
05:37p JOHNSON & JOHNS : European Commission Approves TREVICTA® (paliperido..
05/30 JOHNSON & JOHNS : Canadian class-action launched over Johnson & John..
05/30 Samsung Bioepis receives final European approval for its Remicade..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Johnson & Johnson : J&J in $4 Billion Settlement Talks

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/12/2013 | 11:16pm CEST

Johnson & Johnson (JNJ) has agreed to pay $4 billion to settle more than 7,500 lawsuits over the company's recalled hip-implant products, Bloomberg News reported Tuesday, citing three people familiar with the agreement.

The settlement will be announced next week, Bloomberg reported.

Full story at: www.bloomberg.com/news/2013-11-12/j-j-said-to-reach-4-billion-deal-to-settle-hip- awsuits.html

Write to nymonitoring@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on JOHNSON & JOHNSON
05:37p JOHNSON & JOHNSON : European Commission Approves TREVICTA® (paliperidone palmita..
05/30 JOHNSON & JOHNSON : Canadian class-action launched over Johnson & Johnsons baby ..
05/30 Samsung Bioepis receives final European approval for its Remicade copy
05/29 JOHNSON & JOHNSON : Telling the stories of a son fallen in combat, and also vete..
05/27 JOHNSON & JOHNSON : SIMPONI® Receives CHMP Positive Opinion For Treatment Of Pol..
05/27 JOHNSON & JOHNSON : Remember these? Pinto, Tylenol and other infamous recalls
05/27 JOHNSON & JOHNSON : Canadian class action claims Johnson's baby powder failed to..
05/27 MYOB : Australia’s Best Employers Revealed
05/26 JOHNSON & JOHNSON : Pharma company developing cancer drug moving to Houston
05/25 JOHNSON & JOHNSON : to Participate in the Goldman Sachs 37th Annual Global Healt..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials